Some are mild, like nausea or constipation, and others may be more serious
Regular check-ups are important to make sure the chosen dose is working well for each patient
Semaglutide as a GLP-1 agonist: A breakthrough in obesity treatment
Among non-Hispanic Black individuals, estimated reductions included 18,783 MACE (~ 16), 4,840 cardiovascular deaths (~ 7%), 14,116 nonfatal myocardial infarctions (~ 26%), and 4,116 nonfatal strokes (~ 12%)
Managing Side Effects While initially, you may experience certain side effects, such as nausea or indigestion, these typically diminish over time and with the escalation of doses
( g ) Pie chart of the proportion of TTX-responders or TTX-nonresponders across GnasWT cells (top) and GnasKO cells (bottom) out of the total number of cells